𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

✍ Scribed by Teni, T.R.; Sheth, A.R.; Kamath, M.R.; Sheth, N.A.

Book ID
122813844
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
469 KB
Volume
43
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Urinary cholesterol excretion in men wit
Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate
✍ Dieter Juengst; Angelika Pickel; Erich Elsaesser; Franz J. Marx; Hans J. Karl πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate. Normal range of NEC was determined in 62 healthy individuals and was found to be 0.26-2.2 mg/24 hours (2 SD) with a me

Tissue concentrations of prostate-specif
Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia
✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv